RDS (Rhythm Diagnostic Systems)
↗Strasbourg, France
RDS is a French health-tech company specializing in high-precision remote patient monitoring solutions. Its flagship product, MultiSense®, is a multi-parametric wearable patch designed to continuously monitor vital signs for patients in the hospital or at home. The platform combines advanced biosensors with a cloud-based analytics system to provide actionable clinical insights, aiming to improve patient pathways and facilitate earlier hospital discharge.
Headquartered in Strasbourg, France, RDS operates within the IHU (Institute of Image-Guided Surgery) ecosystem. The company focuses on the 'Hospital-at-Home' market, providing a turnkey solution that includes the wearable device, data transmission, and a clinical dashboard for healthcare providers. RDS is currently expanding its commercial operations across Europe and preparing for entry into the United States market.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Remote Patient Monitoring / Digital Health
SIZE & FINANCIALS
Employees:1-50
Revenue:Generating Revenue
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$25.4M
Investors:Bpifrance, Capital Grand Est, Groupe MACSF, La French Tech Est, Critical Path Ventures, Business France
PIPELINE
Stage:Commercial
Lead Drug Stage:CE Marked / FDA Pending
Modalities:Wearable Biosensors, Cloud Platform, Predictive Analytics
Active Trials:6
Trial Phases:-
FDA Approvals:0
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:IHU Strasbourg, Future4Care Accelerator, PariSanté Campus, USAID (STAMP2 program for Ebola monitoring)
COMPETITION
Position:Emerging
Competitors:BioIntelliSense, VitalConnect, Current Health (Best Buy Health), Masimo, Endotronix, Murata Vios
LEADERSHIP
Key Executives:
Elie Lobel - CEO
Louis Mayaud - CTO
Arnaud Quinet - Head of Sales
Scientific Founders:Sam Eletr, Bruce O'Neil, George Golda
Board Members:Prof. Julien Pottecher, Prof. Jacques Marescaux
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with RDS (Rhythm Diagnostic Systems). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.